Reactivation of hidden-latent Brucella infection after doxycycline and streptomycin treatment in mice

• Published in: Antimicrobial agents and chemotherapy 2024-12, Vol.69 (2), p.e0130224
• Main Authors: Sancho-Sánchez, Eugenia, García-Arteaga, Kimberly, Granados-Chinchilla, Fabio, Artavia, Graciela, Alfaro-Alarcón, Alejandro, Villalobos-Villalobos, Andrés, Bouza-Mora, Laura, Suárez-Esquivel, Marcela, Chacón-Díaz, Carlos, Guzmán-Verri, Caterina, Moreno, Edgardo, Barquero-Calvo, Elías
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Brucella abortus - drug effects; Brucellosis - drug therapy; Brucellosis - microbiology; Doxycycline - pharmacology; Doxycycline - therapeutic use; Experimental Therapeutics; Female; Liver - drug effects; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Spleen - drug effects; Spleen - microbiology; Spleen - pathology; Streptomycin - pharmacology; Streptomycin - therapeutic use; Veterinary Microbiology
• ISSN: 0066-4804; 1098-6596; 1098-6596
• DOI: 10.1128/aac.01302-24

Brucellosis has therapeutic challenges due to 3%-15% relapses/therapeutic failures (R/TF) after antibiotic treatment. Therefore, determining the antibiotic concentration in tissues, the physiopathological parameters, and the R/TF after treatment is relevant. After exploring different antibiotic quantities, we found that a combined dose of 100 µg/g of doxycycline (for 45 days) and 7.5 µg/g of streptomycin (for 14 days), respectively, achieved therapeutic levels of more than fourfold minimum inhibitory concentrations (MICs) against in the spleen, liver, bone marrow, and plasma of mice, causing minimal pathophysiological effects. After 30 days of infection, mice received antibiotics, and hematological, histopathological, biochemical, and immunological analyses were performed. After antibiotic therapy, the pathological, hematological, immunological, and physiological profiles paralleled those described in human brucellosis. Treatment lowered antibody titers, reduced proinflammatory cytokines, and reduced inflammation in the target organs for a protracted period. No bacteria were detected in tissues 8 weeks after treatment, suggesting complete recovery. However, despite high doxycycline and streptomycin concentrations in tissues, relapses appeared in 100% of the animals after 182 days post-infection, estimated by the bacterial counts and PCR from organs. This proportion contrasts with the 15% R/TF observed in humans after antibiotic treatments. None of the isolated from relapses showed augmented MICs or mutations coding for antibiotic resistance in chromosomal-relevant regions. We discuss whether our findings constitute a general phenomenon or differences in the exhaustive screening method for bacteria detection related to the murine model. Along these lines, we envision likely mechanisms of bacterial persistence in tissues after antibiotic treatment.